TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $27,000 | -68.2% | 361 | -88.6% | 0.00% | – |
| Q1 2022 | $85,000 | -81.2% | 3,169 | -66.6% | 0.00% | – |
| Q4 2021 | $453,000 | +225.9% | 9,496 | +352.6% | 0.00% | – |
| Q3 2021 | $139,000 | -89.4% | 2,098 | -87.5% | 0.00% | – |
| Q2 2021 | $1,307,000 | -73.1% | 16,747 | -67.4% | 0.00% | -100.0% |
| Q1 2021 | $4,852,000 | -26.7% | 51,293 | -5.5% | 0.00% | -50.0% |
| Q4 2020 | $6,615,000 | +39.4% | 54,294 | -0.1% | 0.00% | 0.0% |
| Q3 2020 | $4,746,000 | +200.2% | 54,333 | +121.9% | 0.00% | +100.0% |
| Q2 2020 | $1,581,000 | +47.2% | 24,489 | +1.8% | 0.00% | 0.0% |
| Q1 2020 | $1,074,000 | +867.6% | 24,067 | +1254.4% | 0.00% | – |
| Q4 2019 | $111,000 | +2120.0% | 1,777 | +1486.6% | 0.00% | – |
| Q2 2019 | $5,000 | – | 112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |